Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ExoCoBio logo — ExoCoBio improves the quality of life with exosome-based tec...

ExoCoBio

ExoCoBio improves the quality of life with exosome-based technology Our Exosomes Your Future

Founded 2017 Korea South Korea South 28 employees Series C Total: $47.30M Biotechnology, Health Care +2

General Information

Company Name ExoCoBio
Founded Year 2017
Location Korea South Korea South
Founders / Decision Makers
Team member Team member
Employees 28
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Series C
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Licensing
Offices as of Oct 2026
Seoul, Korea South
Social

BounceWatch is an independent company data service, not affiliated with ExoCoBio. To contact ExoCoBio, visit exocobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ExoCoBio compare?

A PDF of ExoCoBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ExoCoBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ExoCoBio

ExoCoBio, established in 2017, is a pioneering company in the Biotechnology sector, focusing on developing exosome-based solutions. Their slogan, "ExoCoBio improves the quality of life with exosome-based technology," underscores their commitment to enhancing human health and wellness.

Positioned at the intersection of Health Care and Wellness Beauty, ExoCoBio differentiates itself as the first and leading company globally in EXOsome COsmeceuticals & BIOpharmaceuticals. Headquartered in Korea South, the company has made significant strides in the Pharmaceutical industry by pioneering innovative applications for exosomes.

In its most recent financing round, ExoCoBio secured a $9.30 million Series C investment on 01 August 2020. This funding featured contributions from notable investors including Focus Assets Management, K2 Investment Partners, Knotus, Dt& Investment, SBI Investment Korea, and G.N. Tech Venture, highlighting strong market confidence in its technological prospects.

Business keywords: Exosome Technology, Cosmeceuticals, Biopharmaceuticals, Stem Cell-Derived Exosomes, Therapeutics Development, Innovative Cosmetics, Quality of Life Improvement, Exosome-Based Products, Personal Care Innovations, Biotech Research, Regenerative Medicine, Advanced Skincare Solutions

Services & Products

R&D in Exosome Technology
Development of Regenerative Therapeutics
Immuno-Oncology Solutions
Biopharmaceutical Product Development
Innovation in Bio Ingredients

Target Customers

Healthcare Providers Pharmaceutical Companies Cosmetic Industry Biotech Companies Dermatology Clinics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $9.30M 6
Focus Assets Management K2 Investment Partners Knotus
Focus Assets Management, K2 Investment Partners +4
01 Aug 2020
Series B $27.00M 8
Atinum Investment Korea Development Bank InterVest
Atinum Investment, Korea Development Bank +6
01 Sep 2018
Series A $11.00M 2
Atinum Investment SBI Investment
Atinum Investment, SBI Investment
01 May 2017

ExoCoBio Alternatives & Competitors

View All Alternatives
ExoCoBio vs
BreStem Therapeutics, Inc.
BreStem Therapeutics, Inc. United States

BreStem is a clinical stage biotech company working to fight deadly lung diseases through stem cell...

1 employees
Biotechnology, Health Care
Compare ExoCoBio vs BreStem Therapeutics, Inc.
ExoCoBio vs
Augustinus Bader
Augustinus Bader United Kingdom

Revolutionary Science, Biological Wisdom.

Private Equity
184 employees
E-Commerce, Health Care
Compare ExoCoBio vs Augustinus Bader
ExoCoBio vs
Sidansai
Sidansai

A Shanghai-based biotechnology company pioneering the advancement of cell therapy.

Series C
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About ExoCoBio

ExoCoBio improves the quality of life with exosome-based technology Our Exosomes Your Future
ExoCoBio was founded in 2017.
ExoCoBio is headquartered in Korea South. As of Oct 2026, it also has offices in Seoul, Korea South.
ExoCoBio operates in Biotechnology, Health Care, Pharmaceutical and Wellness Beauty. Its work centres on Exosome Technology, Cosmeceuticals, Biopharmaceuticals and Stem Cell-Derived Exosomes. Its customers include Healthcare Providers, Pharmaceutical Companies and Cosmetic Industry.
ExoCoBio has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales and Licensing.
ExoCoBio has approximately 28 employees.
ExoCoBio has completed 3 funding rounds, raising a total of $47.30M. The latest funding stage is Series C.
ExoCoBio offers: R&D in Exosome Technology, Development of Regenerative Therapeutics, Immuno-Oncology Solutions, Biopharmaceutical Product Development, Innovation in Bio Ingredients.
Top alternatives and competitors to ExoCoBio include BreStem Therapeutics, Inc., Augustinus Bader, Sidansai, Athersys, ZenBio, A BioIVT Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExoCoBio and BreStem Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ExoCoBio, https://bouncewatch.com/company/exocobio, updated 10 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout